We chatted to IronRidge Resources' CEO Vincent Mascolo who explains why the company has become a lithium explorer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6,953.00
Bid: 6,953.00
Ask: 6,955.00
Change: -57.00 (-0.81%)
Spread: 2.00 (0.03%)
Open: 7,001.00
High: 7,172.00
Low: 6,943.00
Yest. Close: 7,010.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Astra's Trastuzumab Deruxtecan Achieves Tumour Response Rate Of 60.9%

Astra's Trastuzumab Deruxtecan Achieves Tumour Response Rate Of 60.9%

11 Dec 19 13:41

AstraZeneca-Daiichi drug halts cancer for months in first readout

Dec 11 (Reuters) - An experimental cancer drug developed by AstraZeneca and Daiichi Sankyo kept metastatic breast cancer at bay for months in women who had exhausted other treatment options, its first clinical study showed.Patients on trastuzumab ...

11 Dec 19 13:00

Tuesday broker round-up

(Sharecast News) - ASOS: HSBC upgrades to buy with a target price of 3,615p.

10 Dec 19 08:29

DeepMatter shares surge as it announces AstraZeneca collaboration

(Sharecast News) - DeepMatter shares surged on Monday, after it announced a collaboration with AstraZeneca to use digital technologies to improve the productivity and reproducibility of compound synthesis.

9 Dec 19 14:07

UK WINNERS & LOSERS SUMMARY: Tullow Plunges On Output Guidance Reset

UK WINNERS & LOSERS SUMMARY: Tullow Plunges On Output Guidance Reset

9 Dec 19 10:50

UPDATE 2-UK shares weaken, Tullow loses half its market cap

* FTSE 100, FTSE 250 down 0.1%* Tesco outshines the main index* Some domestic stocks gain on election optimism* Tullow Oil plummets after co cancels dividend, CEO exits (Adds company news items, updates share moves)By Muvija M and Shashwat AwasthiDe...

9 Dec 19 09:23

DeepMatter Shares Surge On AstraZeneca DigitalGlassware Collaboration

DeepMatter Shares Surge On AstraZeneca DigitalGlassware Collaboration

9 Dec 19 09:15

Positive Results From AstraZeneca Trial Of Calquence Drug In Leukaemia

Positive Results From AstraZeneca Trial Of Calquence Drug In Leukaemia

9 Dec 19 06:51

AstraZeneca, Merck Get Marketing Authorization In China For Lynparza

AstraZeneca, Merck Get Marketing Authorization In China For Lynparza

5 Dec 19 08:31

AstraZeneca's Lynparza approved for use in China

(Sharecast News) - Biopharmaceutical company AstraZeneca announced on Thursday that Lynparza had been approved in China as a first-line maintenance therapy in BRCA-mutated advanced ovarian cancer.

5 Dec 19 08:27

AstraZeneca-Merck Lynparza wins approval in China for ovarian cancer treatment

Dec 5 (Reuters) - AstraZeneca Plc and Merck & Co Inc said on Thursday that their drug, Lynparza, won approval in China as a first line treatment for a from of ovarian cancer.The approval in China is based on the results from a late-stage study in ...

5 Dec 19 07:11

REFILE-AstraZeneca-Merck Lynparza wins approval in China for ovarian cancer treatment

(Corrects typo in the first paragraph)Dec 5 (Reuters) - AstraZeneca Plc and Merck & Co Inc said on Thursday that their drug, Lynparza, won approval in China as a first line treatment for a form of ovarian cancer.The approval in China is based on th...

5 Dec 19 07:11

AstraZeneca Divests North American Seroquel and Seroquel XR Rights

AstraZeneca Divests North American Seroquel and Seroquel XR Rights

3 Dec 19 08:47

AstraZeneca sells Seroquel rights in US and Canada

(Sharecast News) - AstraZeneca has agreed to sell the commercial rights to 'Seroquel' - quetiapine fumarate immediate release - and 'Seroquel XR' - quetiapine fumarate extended release - in the United States and Canada to Cheplapharm Arzneimittel, it announced on Tuesday.

3 Dec 19 07:29

China to use drug bulk-buy program to close price gap

BEIJING, Nov 30 (Reuters) - China will use its national drug bulk-buy scheme to lower the price of drugs currently sold at higher prices compared with other markets, it said in an official statement.The move could force international drugmakers to...

30 Nov 19 15:47

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.